Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -11.23 |
peg ratio | 0.34 |
price to book ratio | 1.69 |
price to sales ratio | 511.14 |
enterprise value multiple | -10.71 |
price fair value | 1.69 |
profitability ratios | |
---|---|
gross profit margin | 18.35% |
operating profit margin | -5729.08% |
pretax profit margin | -4540.4% |
net profit margin | -4540.4% |
return on assets | -14.37% |
return on equity | -19.42% |
return on capital employed | -18.74% |
liquidity ratio | |
---|---|
current ratio | 22.93 |
quick ratio | 22.93 |
cash ratio | 9.84 |
efficiency ratio | |
---|---|
days of inventory outstanding | 0.00 |
operating cycle | 1.86 |
days of payables outstanding | 1,432.08 |
cash conversion cycle | -1,430.22 |
receivables turnover | 196.15 |
payables turnover | 0.25 |
inventory turnover | 0.00 |
debt and solvency ratios | |
---|---|
debt ratio | 0.02 |
debt equity ratio | 0.02 |
long term debt to capitalization | 0.00 |
total debt to capitalization | 0.02 |
interest coverage | -8.97 |
cash flow to debt ratio | -7.96 |
cash flow ratios | |
---|---|
free cash flow per share | -1.78 |
cash per share | 10.67 |
operating cash flow per share | -1.74 |
free cash flow operating cash flow ratio | 1.02 |
cash flow coverage ratios | -7.96 |
short term coverage ratios | 0.00 |
capital expenditure coverage ratio | -41.66 |
Frequently Asked Questions
IDEAYA Biosciences, Inc. (IDYA) published its most recent earnings results on 04-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. IDEAYA Biosciences, Inc. (NASDAQ:IDYA)'s trailing twelve months ROE is -19.42%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. IDEAYA Biosciences, Inc. (IDYA) currently has a ROA of -14.37%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
IDYA reported a profit margin of -4540.4% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 22.93 in the most recent quarter. The quick ratio stood at 22.93, with a Debt/Eq ratio of 0.02.